IRIDEX Research and Development Expenses 2010-2024 | IRIX
IRIDEX research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
IRIDEX Annual Research and Development Expenses
(Millions of US $) |
| 2023 |
$7 |
| 2022 |
$7 |
| 2021 |
$7 |
| 2020 |
$3 |
| 2019 |
$4 |
| 2018 |
$4 |
| 2017 |
$5 |
| 2016 |
$5 |
| 2015 |
$5 |
| 2014 |
$5 |
| 2013 |
$4 |
| 2012 |
$4 |
| 2011 |
$4 |
| 2010 |
$4 |
| 2009 |
$3 |
IRIDEX Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-03-31 |
$2 |
| 2023-12-31 |
$2 |
| 2023-09-30 |
$2 |
| 2023-06-30 |
$2 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$1 |
| 2022-09-30 |
$2 |
| 2022-06-30 |
$2 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$2 |
| 2021-09-30 |
$2 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$1 |
| 2020-09-30 |
$1 |
| 2020-06-30 |
$1 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
$1 |
| 2019-09-30 |
$1 |
| 2019-06-30 |
$1 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$1 |
| 2018-09-30 |
$1 |
| 2018-06-30 |
$1 |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$1 |
| 2017-09-30 |
$1 |
| 2017-06-30 |
$1 |
| 2017-03-31 |
$1 |
| 2016-12-31 |
$1 |
| 2016-09-30 |
$1 |
| 2016-06-30 |
$1 |
| 2016-03-31 |
$1 |
| 2015-12-31 |
$1 |
| 2015-09-30 |
$1 |
| 2015-06-30 |
$1 |
| 2015-03-31 |
$1 |
| 2014-12-31 |
$1 |
| 2014-09-30 |
$1 |
| 2014-06-30 |
$1 |
| 2014-03-31 |
$1 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$1 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$1 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$1 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$1 |
| 2010-06-30 |
$1 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.037B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
